Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

TRICHINELLA IGG ANTIBODY, ELISA

Geisinger Epic Procedure Code:  LAB3192    Geisinger Epic ID:  7338

SPECIMEN COLLECTION
Specimen type: 

Serum


Preferred collection container: 
Alternate collection container: 
6 mL red-top (plain, non-serum separator) tube
Specimen required: 

1 mL aliquot of serum; minimum 0.1 mL.



SPECIMEN PROCESSING
Processing instructions: 

Centrifuge and immediately separate serum specimens from the cells into clean, plastic, screw-capped vial(s).


Transport temperature: 

Room temperature.


Specimen stability: 

Room Temperature: 7 days. Refrigerated: 14 days. Frozen: 30 days.


Rejection criteria: 

Stability limits exceeded.



TEST DETAILS
Additional information: 

The ELISA technique for the detection of trichinella IgG antibody offers significant improvements in sensitivity compared to the widely-used Bentonite Flocculation (BF) and Latex Agglutination (LA) tests. An excretory-secretory antigen is employed to reduce nonspecific reactivity; however, crossreactivity with other parasitic antigens (e. g., strongyloides, filaria, malaria) may occur. Such crossreactivity is usually associated with results in the equivocal range. The trichinella antibody ELISA must be considered a screening test for trichinella exposure. The diagnosis of trichinosis requires a compatible patient history and supporting pathologic findings.


CPT code(s):  86784
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Methodology: 
Enzyme-Linked Immunosorbent Assay (ELISA)
Synonyms: 

Trichinosis AB, Trichinella IgG Antibody, IgG ELISA, TRICHI, Quest test code 34321


Clinical significance: 

The assay should be considered a screening test for Trichinella exposure; diagnosis of trichinosis requires a compatible patient history and supporting pathologic findings.


Review Date:  12/16/2024

Performing Locations